Reconsidering lung cancer screening: is biannual screening possible?

Affiliations

¹ Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain;; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain;; Instituto de Investigaciones Sanitarias de Santiago (IDIS), Santiago de Compostela, Spain.
² Service of Pneumology, Álvaro Cunqueiro Hospital, Vigo, Spain.
³ Service of Medical Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain;; Instituto de Investigación Puerta de Hierro, Madrid, Spain.

Editorial

Alberto Ruano-Ravina et al. J Thorac Dis. 2016 Sep.

. 2016 Sep;8(9):2372-2375.

doi: 10.21037/jtd.2016.09.30.

¹ Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain;; CIBER de Epidemiología y Salud Pública, CIBERESP, Madrid, Spain;; Instituto de Investigaciones Sanitarias de Santiago (IDIS), Santiago de Compostela, Spain.
² Service of Pneumology, Álvaro Cunqueiro Hospital, Vigo, Spain.
³ Service of Medical Oncology, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain;; Instituto de Investigación Puerta de Hierro, Madrid, Spain.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF Jr, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Patz EF Jr, et al. Lancet Oncol. 2016 May;17(5):590-9. doi: 10.1016/S1470-2045(15)00621-X. Epub 2016 Mar 18. Lancet Oncol. 2016. PMID: 27009070 Free PMC article. Clinical Trial.

1. National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
1. Pinsky PF, Church TR, Izmirlian G, et al. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976-83. 10.1002/cncr.28326 - DOI - PMC - PubMed
1. Ruano-Ravina A, Heleno B, Fernández-Villar A. Lung cancer screening with low-dose CT (LDCT), or when a public health intervention is beyond the patient's benefit. J Epidemiol Community Health 2015;69:99-100. 10.1136/jech-2014-204293 - DOI - PubMed
1. Ruano-Ravina A, Fernández-Villar A, Provencio-Pulla M. Cons: lung cancer screening with low-dose computed tomography. Gac Sanit 2016;30:383-5. 10.1016/j.gaceta.2016.03.003 - DOI - PubMed
1. Shlomi D, Ben-Avi R, Balmor GR, et al. Screening for lung cancer: time for large-scale screening by chest computed tomography. Eur Respir J 2014;44:217-38. 10.1183/09031936.00164513 - DOI - PubMed